BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24708191)

  • 21. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
    Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
    Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
    Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factors.
    Yanagawa M; Tanaka Y; Kusumoto M; Watanabe S; Tsuchiya R; Honda O; Sumikawa H; Inoue A; Inoue M; Okumura M; Tomiyama N; Johkoh T
    Lung Cancer; 2010 Dec; 70(3):286-94. PubMed ID: 20392516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.
    Liu F; Zhao B; Krug LM; Ishill NM; Lim RC; Guo P; Gorski M; Flores R; Moskowitz CS; Rusch VW; Schwartz LH
    J Thorac Oncol; 2010 Jun; 5(6):879-84. PubMed ID: 20421814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PET.
    Morimoto D; Takashima S; Sakashita N; Sato Y; Jiang B; Hakucho T; Miyake C; Takahashi Y; Tomita Y; Nakanishi K; Hosoki T; Higashiyama M
    Acta Radiol; 2014 Jun; 55(5):563-9. PubMed ID: 24003260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma.
    Hashizume T; Yamada K; Okamoto N; Saito H; Oshita F; Kato Y; Ito H; Nakayama H; Kameda Y; Noda K
    Chest; 2008 Feb; 133(2):441-7. PubMed ID: 18071015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
    Zhang H; Wroblewski K; Pu Y
    Acta Radiol; 2012 Jun; 53(5):561-8. PubMed ID: 22661603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility study of FDG PET/CT-derived primary tumour glycolysis as a prognostic indicator of survival in patients with non-small-cell lung cancer.
    Mehta G; Chander A; Huang C; Kelly M; Fielding P
    Clin Radiol; 2014 Mar; 69(3):268-74. PubMed ID: 24315703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computerized texture analysis of persistent part-solid ground-glass nodules: differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas.
    Chae HD; Park CM; Park SJ; Lee SM; Kim KG; Goo JM
    Radiology; 2014 Oct; 273(1):285-93. PubMed ID: 25102296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
    Kim H; Goo JM; Suh YJ; Park CM; Kim YT
    Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
    Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
    Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
    Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
    Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.
    Seok Y; Lee E
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):150-155. PubMed ID: 27517168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H; Wang R; Zhao F; Zhu K; Jiang S; Zhao W; Feng R
    Acta Radiol; 2011 Jul; 52(6):646-50. PubMed ID: 21508201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic tumor burden predicts for disease progression and death in lung cancer.
    Lee P; Weerasuriya DK; Lavori PW; Quon A; Hara W; Maxim PG; Le QT; Wakelee HA; Donington JS; Graves EE; Loo BW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):328-33. PubMed ID: 17869659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival.
    Kawata Y; Niki N; Ohmatsu H; Kusumoto M; Tsuchida T; Eguchi K; Kaneko M; Moriyama N
    Med Phys; 2012 Feb; 39(2):988-1000. PubMed ID: 22320808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.